Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

Ramos finished 2024 with a 27-7 record and a Round of 12 loss to Lehigh’s Luke Stanich ... some indication of where two of top 10 athletes in the weight class stack up and what Crookham ...

Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.

Though relatively few states currently pay for GLP-1s for weight loss, all 12 programs that reported coverage as of early ...

When runners were made 10 percent lighter via a series of pulleys ... exercise, and nutrition programs for holistic weight ...

Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...

For Sprackling, the key to consumers benefiting from GLP-1 medications is responsible use rather than viewing them as a quick ...

NIH Study Demonstrates Long-Term Benefits of Weight-Loss Surgery in Young People - Seeing Greater Remission of Type 2 ...

We expect to select candidates for all three programs in 2025. In obesity, we are advancing WVE-007, our GalNAc-siRNA ...

CinFina Pharma, a CinRx portfolio company dedicated to advancing a portfolio of high-impact treatment options for obesity, today announced topline int ...

Viking isn't a biotech that will need to take out a lot of debt or issue a lot of new shares to get its therapies out the door. Therefore, buying its stock won't leave you at as high of a risk of your ...